USFDA puts on hold Sun Pharma trials on dermatological drug ...Middle East

The US health regulator has directed Sun Pharma to stop trials of a dermatological drug with a 12 mg dose regimen as its usage could lead to blood clots. The drug major on Tuesday said it had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose in one of the long-term Open Label Extension (OLE) studies.

Hence then, the article about usfda puts on hold sun pharma trials on dermatological drug was published today ( Tuesday 02/05/2023 - 01:00 PM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( USFDA puts on hold Sun Pharma trials on dermatological drug )

Also on site :

• Voices: ‘Rip-off Britain’: Readers clash over rise of illegal streaming and ‘dodgy sticks’
• India Jazz Project: Bridging Cultures with Blues Legends Tinariwen
• INSV Kaundinya: Reviving Ancient Indian Maritime Heritage